Sabril 500 Tablets contain Vigabatrin, an effective anticonvulsant medication specifically designed to manage epilepsy by controlling complex partial seizures and infantile spasms. Vigabatrin in Sabril works by irreversibly inhibiting the enzyme GABA transaminase, increasing gamma-aminobutyric acid (GABA) levels in the brain, which reduces neuronal excitability and prevents seizure activity. Each tablet delivers a 500 mg dose of Vigabatrin, designed according to rigorous pharmaceutical manufacturing standards to ensure high quality, purity, and safety. This product is intended for prescription use where healthcare professionals determine the appropriate dosing based on individual patient condition and responsiveness. Regular monitoring is essential, particularly for vision-related side effects, which may be severe and require immediate medical attention. Sabril 500 Tablets offer targeted therapeutic benefits for epilepsy patients requiring adjunctive treatment to achieve seizure control.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Vigabatrin 500 mg per tablet |
| Indications | Treatment of complex partial seizures and infantile spasms in epilepsy |
| Mechanism of Action | Inhibits GABA transaminase enzyme to increase brain GABA levels |
| Dosage Form | Oral tablets |
| Manufacturing Standards | Produced under stringent pharmaceutical quality control |
| Packaging | Available in blister strips with variable tablet counts |
| Usage Instruction | Dosage determined by healthcare provider based on patient needs |
| Safety Monitoring | Requires regular eye monitoring for potential vision complications |
| Patient Compliance | Strict adherence to prescribed dosage recommended |
| Therapeutic Class | Anticonvulsant / Epilepsy management |
| Attributes | Description |
|---|---|
| Tablet Strength | 500 mg Vigabatrin |
| Tablet Type | Film-coated tablet |
| Indications | Complex partial seizures, infantile spasms |
| Pharmacological Action | Increases inhibitory neurotransmitter GABA concentration |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Shelf Life | Typically 24 months from manufacturing date |
| Dosage Form | Oral administration |
| Country of Manufacture | Varies - produced following GMP guidelines |
| Prescription Status | Schedule H - prescription only |
| Potential Side Effects | Vision loss, dizziness, fatigue, and other neurological symptoms |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Sabril 500 Tablets are primarily used to manage epilepsy, focusing on controlling complex partial seizures and infantile spasms via the anticonvulsant Vigabatrin.
Vigabatrin works by inhibiting the enzyme responsible for breaking down GABA, a neurotransmitter that calms nerve activity in the brain, thereby helping to prevent seizures.
Yes, patients must undergo regular ophthalmologic examinations since Vigabatrin can cause irreversible vision loss or other eye-related adverse effects.
No, dosage adjustments should only be done by a healthcare provider based on individual patient response and clinical condition.
Patients should immediately report any signs of vision changes such as blurriness, loss of peripheral vision, or other visual disturbances, as well as neurological symptoms like dizziness or drowsiness.
Inclusive of all taxes
You Save: 0
Bengaluru , India
Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler
GST- 29AQTPJ8785C1Z2
